Patents by Inventor Hisayuki TAKAMATSU

Hisayuki TAKAMATSU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME
    Publication number: 20240239756
    Abstract: A method for treating or preventing a disease involving autotaxin including administering a carboxylic acid compound of formula (1) or a pharmacologically acceptable salt thereof to a patient in need thereof.
    Type: Application
    Filed: March 13, 2024
    Publication date: July 18, 2024
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi TAKAHASHI, Hisayuki TAKAMATSU, Daisuke IIJIMA, Shuzo TAKEDA
  • 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same
    Patent number: 11958812
    Abstract: Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein each symbol is as defined in the SPECIFICATION.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: April 16, 2024
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi Takahashi, Hisayuki Takamatsu, Daisuke Iijima, Shuzo Takeda
  • NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME
    Publication number: 20220298118
    Abstract: Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein each symbol is as defined in the SPECIFICATION.
    Type: Application
    Filed: July 26, 2019
    Publication date: September 22, 2022
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi TAKAHASHI, Hisayuki TAKAMATSU, Daisuke llJIMA, Shuzo TAKEDA
  • 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof
    Patent number: 9783522
    Abstract: Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I): [wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: October 10, 2017
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi Takahashi, Akinori Umino, Daisuke Iijima, Hisayuki Takamatsu
  • NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF
    Publication number: 20170044133
    Abstract: Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I): [wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 16, 2017
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Taichi TAKAHASHI, Akinori UMINO, Daisuke IIJIMA, Hisayuki TAKAMATSU